Beroni Group News Today

Beroni Group Limited advises that it has entered into an unsecured and interest free convertible loan agreement with a group of investors for a principal loan amount of US$410,397. The loan is...

Beroni Group Limited (NSX:BTG) Beroni Enters Into Convertible Loan With Investor

Beroni Group Limited (OTCMKTS:BNIGF) (NSX:BTG) advises that it has entered into unsecured and interest free convertible loan agreements with two investors for an aggregate principal loan amount of US$291,545.

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, Chi...

Beroni Group Limited (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based biopharmaceutical enterprise, announced that its enhanced COVID-19 Antigen Rapid Test Kit - Colloidal Gold Method has been undergoing clinical trial in China, for eventual application to the National Medical Product Administration.

Beroni Group (OTCMKTS:BNIGF) (NSX:BTG) announced that it has received notification that its latest enhanced COVID-19 Antigen Rapid Test Kit has complied with the applicable essential requirements of the council directive 98/79/EEC in vitro diagnostics as amended.

NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based...

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors - read this article along with other careers information, tips and advice on BioSpace

Sydney, Australia - Beroni Group Limited an Australia-based biopharmaceutical enterprise, today announced that its article entitled "Crystal structures of the SARS-CoV-2 nucleocapsid protein C-terminal domain and development of nucleocapsid-targeting nanobodies" has been accepted for publication and undergone full review in the FEBS Journal. The FEBS Journal is an international peer-reviewed non-profit society ...

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, Chi...